OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Purchases 1,190,476 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa acquired 1,190,476 shares of the firm’s stock in a transaction that occurred on Friday, June 20th. The stock was bought at an average price of $0.42 per share, for a total transaction of $499,999.92. Following the completion of the transaction, the director owned 15,152,796 shares of the company’s stock, valued at $6,364,174.32. The trade was a 8.53% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

Thomas Kosasa also recently made the following trade(s):

• On Wednesday, September 24th, Thomas Kosasa acquired 6,000 shares of OneMedNet stock. The shares were purchased at an average cost of $0.93 per share, for a total transaction of $5,580.00.
• On Friday, August 29th, Thomas Kosasa bought 581,395 shares of OneMedNet stock. The stock was acquired at an average price of $0.86 per share, for a total transaction of $499,999.70.

OneMedNet Stock Down 2.7%

NASDAQ:ONMD opened at $1.42 on Thursday. The company has a fifty day moving average of $1.77 and a 200 day moving average of $0.99. The firm has a market capitalization of $72.43 million, a P/E ratio of -28.40 and a beta of 1.09. OneMedNet Corporation has a 52 week low of $0.30 and a 52 week high of $4.22.

OneMedNet (NASDAQ:ONMD) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.18 million during the quarter.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ONMD. Wall Street Zen raised shares of OneMedNet to a “hold” rating in a research report on Friday, September 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of OneMedNet in a research note on Tuesday, October 14th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, OneMedNet has an average rating of “Sell”.

Institutional Trading of OneMedNet

Large investors have recently made changes to their positions in the stock. Ashton Thomas Private Wealth LLC bought a new position in OneMedNet during the third quarter valued at approximately $25,000. Exencial Wealth Advisors LLC grew its position in OneMedNet by 3.1% in the 2nd quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock worth $851,000 after purchasing an additional 45,448 shares during the period. Finally, Correct Capital Wealth Management purchased a new stake in OneMedNet during the 3rd quarter valued at $4,910,000. 0.95% of the stock is currently owned by institutional investors.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.